Verotoxin induces rapid elimination of human renal tumor xenografts in scid mice

Journal of Urology

Volumn 171, Issue 3, 2004, Pages 1309-1313

  Ishitoya, Satoshi ^a   Kurazono, Hisao ^b   Nishiyama, Hiroyuki ^a   Nakamura, Eijiro ^a   Kamoto, Toshiyuki ^a   Habuchi, Tomonori ^a   Terai, Akito ^a   Ogawa, Osamu ^a   Yamamoto, Shingo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Carcinoma; Kidney; Mice; Renal cell; SCID; Shiga toxins

Indexed keywords

EOSIN; GLOBOTRIAOSYLCERAMIDE; HEMATOXYLIN; TETRAZOLIUM; VEROTOXIN; VEROTOXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUMOR; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SCID MOUSE; TESTIS TUMOR; TUMOR XENOGRAFT;

EID: 1542327739     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000100110.11129.85     Document Type: Article

References (20)

1. Head, S. C., Karmali, M. A., Roscoe, M. E., Petric, M., Strockbine, N. A. and Wachsmuth, I. K.: Serological differences between verocytoxin 2 and shiga-like toxin II. Lancet, 2: 751, 1988
2. Hii, J. H., Gyles, C., Morooka, T., Karmali, M. A., Clarke, R., Degrandis, S. et al: Development of verotoxin-2 and verotoxin-2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E 32511 and B2F1. J Clin Microbiol, 29: 2704, 1991
3. Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J. L., DeGrandis, S. et al: Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem, 262: 8834, 1987
4. Jacewicz, M., Clausen, H., Nudelman, E., Donohue-Rolfe, A. and Keusch, G. T.: Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide J Exp Med, 163: 1391, 1986
5. Boyd, B. and Lingwood, C.: Verotoxin receptor glycolipid in human renal tissue. Nephron, 51: 207, 1989
6. van de Kar, N. C., Monnens, L. A., Karmali, M. A. and van Hinsbergh, V. W.: Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood, 80: 2755, 1992
7. Saito, S., Orikasa, S., Ohyama, C., Satoh, M. and Fukushi, Y.: Changes in glycolipids in human renal-cell carcinoma and their clinical significance. Int J Cancer, 49: 329, 1991
8. Taguchi, T., Uchida, H., Kiyokawa, N., Mori, T., Sato, N., Horie, H. et al: Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int, 53: 1681, 1998
9. Ohyama, C., Fukushi, Y., Satoh, M., Saito, S., Orikasa, S., Nudelman, E. et al: Changes in glycolipid expression in human testicular tumor. Int J Cancer, 45: 1040, 1990
10. Farkas-Himsley, H., Hill, R., Rosen, B., Arab, S. and Lingwood, C. A.: The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci USA, 92: 6996, 1995
11. Arab, S., Murakami, M., Dirks, P., Boyd, B., Hubbard, S., Lingwood, C. et al: Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells. J Neuroloncol, 40: 137, 1998
12. Arab, S., Rutka, J. and Lingwood, C.: Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol Res, 11: 33, 1999
13. Noda, M., Yutsudo, T., Nakabayashi, N., Hirayama, T. and Takeda, Y.: Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb Pathog, 2: 339, 1987
14. Wiels, J., Fellous, M. and Tursz, T.: Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Nat Acad Sci USA, 78: 6485, 1981
15. Novick, A. C. and Campcell, S. C.: Renal tumors. In: Campbell's Urology, 8th ed. Edited by A. B. Retik, E. D. Vaughan, Jr. and A. J. Wein. Philadelphia: W. B. Saunders Co., vol. 4, chapt. 75, p. 2672, 2002
16. Quesada, J. R., Swanson, D. A., Trinidade, A. and Gutterman, J. U.: Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res, 43: 940, 1983
17. Head, S. C., Karmali, M. A. and Lingwood, C. A.: Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem, 266: 3617, 1991
18. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T. and Igarashi, K.: Site of action of a Vero toxin (VT2) from Escherichia coli O157: H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem, 171: 45, 1988
19. Aoyama, T., Hosseinkhani, H., Yamamoto, S., Ogawa, O. and Tabata, Y.: Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. J Controlled Release, 80: 345, 2002
20. Aoyama, T., Yamamoto, S., Kanematsu, A., Ogawa, O. and Tabata, Y.: Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. Unpublished data